Unraveling Cancer

Fixed vs. Continuous CLL Treatment Explained

In this episode of the Patient Power podcast, Unraveling Cancer, patient host BradAdams is joined by Paul J. Hampel, MD, a hematologist-oncologist at Mayo Clinic in Rochester,for a conversation about fixed duration versus continuous treatment for chronic lymphocyticleukemia (CLL), including benefits, side effects, monitoring, and how to choose the best optionbased on your lifestyle and disease features.

New Immune Advances in CLL

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Michele Nadeem-Baker is joined by Thomas Kipps, MD, PhD, UC San Diego, for a conversation about the latest immune-based advances in chronic lymphocytic leukemia (CLL), including targeted therapies, CAR T-cell treatment, vaccines, and infection prevention. Learn how new research is improving outcomes and bringing hope for a future cure.

Is Fixed Duration Therapy the New Standard?

Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.

From Diagnosis to Treatment End: Navigating Fixed-Duration Therapy for CLL

Physician assistant Jill Miller shares what CLL patients really need to know about fixed-duration treatment. Learn how to manage side effects, what to expect month by month, when treatment ends, and how to navigate the emotional transition from active therapy to surveillance.

Functional Cure? The Promise of CLL Combination Therapy

In this episode of Patient Power’s podcast Unraveling Cancer, patient host Michele Nadeem-Baker speaks with Daniel Ermann, MD, Huntsman Cancer Institute, about how combination therapies are revolutionizing treatment for chronic lymphocytic leukemia. Dr. Ermann shares updates from recent clinical trials, the growing reality of chemo-free treatment, and promising developments such as bispecific antibodies and CAR T-cell therapy. The conversation gives patients insight into the rapidly advancing world of CLL care and what’s on the horizon.
 

Strategies to Combat Fatigue

In this episode of Patient Power’s podcast Unraveling Cancer, patient hostMichele Nadeem-Baker sits down with Lucy Potter, MD, MPH, MD Anderson,for a conversation about one of the most common challenges in cancer care:fatigue. They explore practical behavioral strategies to ease day-to-dayexhaustion, discuss when medications may be helpful, and highlight keytests that can uncover underlying causes.

Choosing Between CLL Treatments

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Michele Nadeem-Baker is joined by Deborah Stephens, DO, UNC at Chapel Hill, for a conversation about choosing a treatment for CLL, when to consider a clinical trial and the pros and cons of fixed duration vs continuous therapy.

Getting the Most Out of Your Doctor’s Visit

In this episode of the Patient Power podcast, Unraveling Cancer, patient host,Michele Nadeem-Baker is joined by Kerry Rogers, MD, from The Ohio StateUniversity, for a conversation about preparing for an upcoming doctor’s visit,how to have a productive conversation about treatment decisions and whatto do when you don’t feel you are being heard.

Treating CLL in Older Adults

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Brad Adams is joined by Thomas Kipps, MD UC San Diego, for a conversation about why the move from chemotherapy to targeted treatments is a game changer for older CLL patients and those with co-morbidities.

Unraveling Cancer: Frontline Therapies for Mantle Cell Lymphoma

In this episode of the Patient Power podcast, Unraveling Cancer, patient hostLarry Fagan is joined by Benjamin Heyman, MD, UC San Diego, for aconversation about frontline therapies for mantle cell lymphoma, the resultsfrom the ECHO trial, and the role of combination treatments in a frontlinesetting moving forward.